EMEA Vaccine Adjuvants Market by Manufacturers, Regions, Type and Application, Forecast to 2022

October 2017 | 124 pages | ID: E77F485D117EN
GlobalInfoResearch

Abstracts

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Scope of the Report:

This report focuses on the Vaccine Adjuvants in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• SEPPIC
• SDA BIO
• Brenntag Biosector
• SPI Pharma
• MVP Laboratories
• Tj Kaiwei
• Novavax
• Zhuoyue
• Aphios
• GSK
• CSL Limited
• Brenntag Biosector
• SEPPIC
• SPI Pharma
• Novavax
• Avanti Polar Lipids
• Aphios

Market Segment by Regions, regional analysis covers

• Europe (Germany, France, UK, Russia, Italy and Turkey)
• Middle East (Saudi Arabia, Israel, UAE and Iran)
• Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

• Oral
• Subcutaneous
• Intramuscular
• Others

Market Segment by Applications, can be divided into

• Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
• Human Vaccine Adjuvants (Research Applications, Commercial Applications)

There are 13 Chapters to deeply display the EMEA Vaccine Adjuvants market.

Chapter 1, to describe Vaccine Adjuvants Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Vaccine Adjuvants, with sales, revenue, and price of Vaccine Adjuvants, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Vaccine Adjuvants, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Vaccine Adjuvants research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Vaccine Adjuvants Introduction
1.2 Market Analysis by Type
  1.2.1 Oral
  1.2.2 Subcutaneous
  1.2.3 Intramuscular
  1.2.4 Others
1.3 Market Analysis by Applications
  1.3.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
  1.3.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 SEPPIC
  2.1.1 Business Overview
  2.1.2 Vaccine Adjuvants Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 SDA BIO
  2.2.1 Business Overview
  2.2.2 Vaccine Adjuvants Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Brenntag Biosector
  2.3.1 Business Overview
  2.3.2 Vaccine Adjuvants Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 SPI Pharma
  2.4.1 Business Overview
  2.4.2 Vaccine Adjuvants Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 MVP Laboratories
  2.5.1 Business Overview
  2.5.2 Vaccine Adjuvants Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Tj Kaiwei
  2.6.1 Business Overview
  2.6.2 Vaccine Adjuvants Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novavax
  2.7.1 Business Overview
  2.7.2 Vaccine Adjuvants Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Zhuoyue
  2.8.1 Business Overview
  2.8.2 Vaccine Adjuvants Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aphios
  2.9.1 Business Overview
  2.9.2 Vaccine Adjuvants Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 GSK
  2.10.1 Business Overview
  2.10.2 Vaccine Adjuvants Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 CSL Limited
  2.11.1 Business Overview
  2.11.2 Vaccine Adjuvants Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Brenntag Biosector
  2.12.1 Business Overview
  2.12.2 Vaccine Adjuvants Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 SEPPIC
  2.13.1 Business Overview
  2.13.2 Vaccine Adjuvants Type and Applications
    2.13.2.1 Type
    2.13.2.2 Type
  2.13.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 SPI Pharma
  2.14.1 Business Overview
  2.14.2 Vaccine Adjuvants Type and Applications
    2.14.2.1 Type
    2.14.2.2 Type
  2.14.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Novavax
  2.15.1 Business Overview
  2.15.2 Vaccine Adjuvants Type and Applications
    2.15.2.1 Type
    2.15.2.2 Type
  2.15.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Avanti Polar Lipids
  2.16.1 Business Overview
  2.16.2 Vaccine Adjuvants Type and Applications
    2.16.2.1 Type
    2.16.2.2 Type
  2.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Aphios
  2.17.1 Business Overview
  2.17.2 Vaccine Adjuvants Type and Applications
    2.17.2.1 Type
    2.17.2.2 Type
  2.17.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA VACCINE ADJUVANTS MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA Vaccine Adjuvants Sales and Market Share by Manufacturer
3.2 EMEA Vaccine Adjuvants Revenue and Market Share by Manufacturer
3.3 EMEA Vaccine Adjuvants Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Vaccine Adjuvants Manufacturer Market Share
  3.4.2 Top 5 Vaccine Adjuvants Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA VACCINE ADJUVANTS MARKET ANALYSIS BY REGIONS

4.1 EMEA Vaccine Adjuvants Sales, Revenue and Market Share by Regions
  4.1.1 EMEA Vaccine Adjuvants Sales by Regions (2012-2017)
  4.1.2 EMEA Vaccine Adjuvants Revenue by Regions (2012-2017)
4.2 Europe Vaccine Adjuvants Sales and Growth (2012-2017)
4.3 Middle East Vaccine Adjuvants Sales and Growth (2012-2017)
4.4 Africa Vaccine Adjuvants Sales and Growth (2012-2017)

5 EUROPE VACCINE ADJUVANTS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe Vaccine Adjuvants Sales, Revenue and Market Share by Countries
  5.1.1 Europe Vaccine Adjuvants Sales by Countries (2012-2017)
  5.1.2 Europe Vaccine Adjuvants Revenue by Countries (2012-2017)
  5.1.3 Germany Vaccine Adjuvants Sales and Growth (2012-2017)
  5.1.4 France Vaccine Adjuvants Sales and Growth (2012-2017)
  5.1.5 UK Vaccine Adjuvants Sales and Growth (2012-2017)
  5.1.6 Russia Vaccine Adjuvants Sales and Growth (2012-2017)
  5.1.7 Italy Vaccine Adjuvants Sales and Growth (2012-2017)
  5.1.8 Turkey Vaccine Adjuvants Sales and Growth (2012-2017)
5.2 Europe Vaccine Adjuvants Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe Vaccine Adjuvants Sales by Manufacturers (2016-2017)
  5.2.2 Europe Vaccine Adjuvants Revenue by Manufacturers (2016-2017)
5.3 Europe Vaccine Adjuvants Sales by Type (2012-2017)
5.4 Europe Vaccine Adjuvants Sales by Application (2012-2017)

6 MIDDLE EAST VACCINE ADJUVANTS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East Vaccine Adjuvants Sales, Revenue and Market Share by Countries
  6.1.1 Middle East Vaccine Adjuvants Sales by Countries (2012-2017)
  6.1.2 Middle East Vaccine Adjuvants Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia Vaccine Adjuvants Sales and Growth (2012-2017)
  6.1.4 Israel Vaccine Adjuvants Sales and Growth (2012-2017)
  6.1.5 UAE Vaccine Adjuvants Sales and Growth (2012-2017)
  6.1.6 Iran Vaccine Adjuvants Sales and Growth (2012-2017)
6.2 Middle East Vaccine Adjuvants Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East Vaccine Adjuvants Sales by Manufacturers (2016-2017)
  6.2.2 Middle East Vaccine Adjuvants Revenue by Manufacturers (2016-2017)
6.3 Middle East Vaccine Adjuvants Sales by Type (2012-2017)
6.4 Middle East Vaccine Adjuvants Sales by Application (2012-2017)

7 AFRICA VACCINE ADJUVANTS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa Vaccine Adjuvants Sales, Revenue and Market Share by Countries
  7.1.1 Africa Vaccine Adjuvants Sales by Countries (2012-2017)
  7.1.2 Africa Vaccine Adjuvants Revenue by Countries (2012-2017)
  7.1.3 South Africa Vaccine Adjuvants Sales and Growth (2012-2017)
  7.1.4 Nigeria Vaccine Adjuvants Sales and Growth (2012-2017)
  7.1.5 Egypt Vaccine Adjuvants Sales and Growth (2012-2017)
  7.1.6 Algeria Vaccine Adjuvants Sales and Growth (2012-2017)
7.2 Middle East Vaccine Adjuvants Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East Vaccine Adjuvants Sales by Manufacturers (2016-2017)
  7.2.2 Middle East Vaccine Adjuvants Revenue by Manufacturers (2016-2017)
7.3 Middle East Vaccine Adjuvants Sales by Type (2012-2017)
7.4 Middle East Vaccine Adjuvants Sales by Application (2012-2017)

8 EMEA VACCINE ADJUVANTS MARKET SEGMENT BY TYPE

8.1 EMEA Vaccine Adjuvants Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA Vaccine Adjuvants Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA Vaccine Adjuvants Revenue and Market Share by Type (2012-2017)
8.2 Oral Sales Growth and Price
  10.2.1 EMEA Oral Sales Growth (2012-2017)
  10.2.2 EMEA Oral Price (2012-2017)
8.3 Subcutaneous Sales Growth and Price
  10.3.1 EMEA Subcutaneous Sales Growth (2012-2017)
  10.3.2 EMEA Subcutaneous Price (2012-2017)
8.4 Intramuscular Sales Growth and Price
  10.4.1 EMEA Intramuscular Sales Growth (2012-2017)
  10.4.2 EMEA Intramuscular Price (2012-2017)
8.5 Others Sales Growth and Price
  10.5.1 EMEA Others Sales Growth (2012-2017)
  10.5.2 EMEA Others Price (2012-2017)

9 EMEA VACCINE ADJUVANTS MARKET SEGMENT BY APPLICATION

9.1 EMEA Vaccine Adjuvants Sales Market Share by Application (2012-2017)
9.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
9.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)

10 EMEA VACCINE ADJUVANTS MARKET FORECAST (2017-2022)

10.1 EMEA Vaccine Adjuvants Sales, Revenue and Growth Rate (2017-2022)
10.2 Vaccine Adjuvants Market Forecast by Regions (2017-2022)
  10.2.1 Europe Vaccine Adjuvants Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.1.2 France Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.1.3 UK Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.1.4 Russia Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.1.5 Italy Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.1.6 Turkey Vaccine Adjuvants Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.2.2 Israel Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.2.3 UAE Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.2.4 Iran Vaccine Adjuvants Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.3.2 Nigeria Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.3.3 Egypt Vaccine Adjuvants Sales Forecast 2017-2022
    10.2.3.4 Algeria Vaccine Adjuvants Sales Forecast 2017-2022
10.3 Vaccine Adjuvants Market Forecast by Type (2017-2022)
10.4 Vaccine Adjuvants Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Vaccine Adjuvants Picture
Table Product Specifications of Vaccine Adjuvants
Figure EMEA Sales Market Share of Vaccine Adjuvants by Types in 2016
Table Vaccine Adjuvants Types for Major Manufacturers
Figure Oral Picture
Figure Subcutaneous Picture
Figure Intramuscular Picture
Figure Others Picture
Table Vaccine Adjuvants Sales Market Share by Applications in 2016
Figure Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure Human Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure Germany Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure France Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure UK Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Vaccine Adjuvants Revenue (Value) and Growth Rate (2012-2022)
Table SEPPIC Basic Information, Manufacturing Base and Competitors
Table SEPPIC Vaccine Adjuvants Type and Applications
Table SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SDA BIO Basic Information, Manufacturing Base and Competitors
Table SDA BIO Vaccine Adjuvants Type and Applications
Table SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table Brenntag Biosector Vaccine Adjuvants Type and Applications
Table Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SPI Pharma Basic Information, Manufacturing Base and Competitors
Table SPI Pharma Vaccine Adjuvants Type and Applications
Table SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MVP Laboratories Basic Information, Manufacturing Base and Competitors
Table MVP Laboratories Vaccine Adjuvants Type and Applications
Table MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Tj Kaiwei Basic Information, Manufacturing Base and Competitors
Table Tj Kaiwei Vaccine Adjuvants Type and Applications
Table Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novavax Basic Information, Manufacturing Base and Competitors
Table Novavax Vaccine Adjuvants Type and Applications
Table Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Zhuoyue Basic Information, Manufacturing Base and Competitors
Table Zhuoyue Vaccine Adjuvants Type and Applications
Table Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aphios Basic Information, Manufacturing Base and Competitors
Table Aphios Vaccine Adjuvants Type and Applications
Table Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Vaccine Adjuvants Type and Applications
Table GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Limited Basic Information, Manufacturing Base and Competitors
Table CSL Limited Vaccine Adjuvants Type and Applications
Table CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table Brenntag Biosector Vaccine Adjuvants Type and Applications
Table Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SEPPIC Basic Information, Manufacturing Base and Competitors
Table SEPPIC Vaccine Adjuvants Type and Applications
Table SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SPI Pharma Basic Information, Manufacturing Base and Competitors
Table SPI Pharma Vaccine Adjuvants Type and Applications
Table SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novavax Basic Information, Manufacturing Base and Competitors
Table Novavax Vaccine Adjuvants Type and Applications
Table Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
Table Avanti Polar Lipids Vaccine Adjuvants Type and Applications
Table Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aphios Basic Information, Manufacturing Base and Competitors
Table Aphios Vaccine Adjuvants Type and Applications
Table Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure EMEA Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure EMEA Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table EMEA Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure EMEA Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure EMEA Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table EMEA Vaccine Adjuvants Price by Manufacturer (2016-2017)
Figure EMEA Vaccine Adjuvants Sales and Growth (2012-2017)
Figure EMEA Vaccine Adjuvants Revenue and Growth (2012-2017)
Table EMEA Vaccine Adjuvants Sales by Regions (2012-2017)
Table EMEA Vaccine Adjuvants Sales Market Share by Regions (2012-2017)
Figure EMEA Vaccine Adjuvants Sales Market Share by Regions in 2012
Figure EMEA Vaccine Adjuvants Sales Market Share by Regions in 2016
Table EMEA Vaccine Adjuvants Revenue by Regions (2012-2017)
Table EMEA Vaccine Adjuvants Revenue Market Share by Regions (2012-2017)
Figure EMEA Vaccine Adjuvants Revenue Market Share by Regions in 2012
Figure EMEA Vaccine Adjuvants Revenue Market Share by Regions in 2016
Figure Europe Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Middle East Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Africa Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Europe Vaccine Adjuvants Revenue and Growth (2012-2017)
Table Europe Vaccine Adjuvants Sales by Countries (2012-2017)
Table Europe Vaccine Adjuvants Sales Market Share by Countries (2012-2017)
Figure Europe Vaccine Adjuvants Sales Market Share by Countries in 2012
Figure Europe Vaccine Adjuvants Sales Market Share by Countries in 2016
Table Europe Vaccine Adjuvants Revenue by Countries (2012-2017)
Table Europe Vaccine Adjuvants Revenue Market Share by Countries (2012-2017)
Figure Europe Vaccine Adjuvants Revenue Market Share by Countries in 2012
Figure Europe Vaccine Adjuvants Revenue Market Share by Countries in 2016
Figure Germany Vaccine Adjuvants Sales and Growth (2012-2017)
Figure France Vaccine Adjuvants Sales and Growth (2012-2017)
Figure UK Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Russia Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Italy Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Turkey Vaccine Adjuvants Sales and Growth (2012-2017)
Table Europe Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Europe Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Europe Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Europe Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Europe Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure Europe Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table Europe Vaccine Adjuvants Sales by Type (2012-2017)
Table Europe Vaccine Adjuvants Sales Share by Type (2012-2017)
Table Europe Vaccine Adjuvants Sales by Application (2012-2017)
Table Europe Vaccine Adjuvants Sales Share by Application (2012-2017)
Figure Middle East Vaccine Adjuvants Revenue and Growth (2012-2017)
Table Middle East Vaccine Adjuvants Sales by Countries (2012-2017)
Table Middle East Vaccine Adjuvants Sales Market Share by Countries (2012-2017)
Figure Middle East Vaccine Adjuvants Sales Market Share by Countries in 2012
Figure Middle East Vaccine Adjuvants Sales Market Share by Countries in 2016
Table Middle East Vaccine Adjuvants Revenue by Countries (2012-2017)
Table Middle East Vaccine Adjuvants Revenue Market Share by Countries (2012-2017)
Figure Middle East Vaccine Adjuvants Revenue Market Share by Countries in 2012
Figure Middle East Vaccine Adjuvants Revenue Market Share by Countries in 2016
Figure Saudi Arabia Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Israel Vaccine Adjuvants Sales and Growth (2012-2017)
Figure UAE Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Iran Vaccine Adjuvants Sales and Growth (2012-2017)
Table Middle East Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Middle East Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Middle East Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Middle East Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Middle East Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure Middle East Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table Middle East Vaccine Adjuvants Sales by Type (2012-2017)
Table Middle East Vaccine Adjuvants Sales Share by Type (2012-2017)
Table Middle East Vaccine Adjuvants Sales by Application (2012-2017)
Table Middle East Vaccine Adjuvants Sales Share by Application (2012-2017)
Figure Africa Vaccine Adjuvants Revenue and Growth (2012-2017)
Table Africa Vaccine Adjuvants Sales by Countries (2012-2017)
Table Africa Vaccine Adjuvants Sales Market Share by Countries (2012-2017)
Figure Africa Vaccine Adjuvants Sales Market Share by Countries in 2012
Figure Africa Vaccine Adjuvants Sales Market Share by Countries in 2016
Table Africa Vaccine Adjuvants Revenue by Countries (2012-2017)
Table Africa Vaccine Adjuvants Revenue Market Share by Countries (2012-2017)
Figure Africa Vaccine Adjuvants Revenue Market Share by Countries in 2012
Figure Africa Vaccine Adjuvants Revenue Market Share by Countries in 2016
Figure South Africa Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Nigeria Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Egypt Vaccine Adjuvants Sales and Growth (2012-2017)
Figure Algeria Vaccine Adjuvants Sales and Growth (2012-2017)
Table Middle East Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Middle East Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Middle East Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Middle East Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Middle East Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure Middle East Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table Middle East Vaccine Adjuvants Sales by Type (2012-2017)
Table Middle East Vaccine Adjuvants Sales Share by Type (2012-2017)
Table Middle East Vaccine Adjuvants Sales by Application (2012-2017)
Table Middle East Vaccine Adjuvants Sales Share by Application (2012-2017)
Table EMEA Vaccine Adjuvants Sales by Type (2012-2017)
Table EMEA Vaccine Adjuvants Sales Share by Type (2012-2017)
Table EMEA Vaccine Adjuvants Revenue by Type (2012-2017)
Table EMEA Vaccine Adjuvants Revenue Share by Type (2012-2017)
Figure EMEA Oral Sales Growth (2012-2017)
Figure EMEA Oral Price (2012-2017)
Figure EMEA Subcutaneous Sales Growth (2012-2017)
Figure EMEA Subcutaneous Price (2012-2017)
Figure EMEA Intramuscular Sales Growth (2012-2017)
Figure EMEA Intramuscular Price (2012-2017)
Figure EMEA Others Sales Growth (2012-2017)
Figure EMEA Others Price (2012-2017)
Table EMEA Vaccine Adjuvants Sales by Application (2012-2017)
Table EMEA Vaccine Adjuvants Sales Share by Application (2012-2017)
Figure EMEA Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
Figure EMEA Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
Figure EMEA Vaccine Adjuvants Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Vaccine Adjuvants Sales Forecast by Regions (2017-2022)
Table EMEA Vaccine Adjuvants Market Share Forecast by Regions (2017-2022)
Table Europe Vaccine Adjuvants Sales Forecast by Regions (2017-2022)
Figure Germany Vaccine Adjuvants Sales Forecast 2017-2022
Figure France Vaccine Adjuvants Sales Forecast 2017-2022
Figure UK Vaccine Adjuvants Sales Forecast 2017-2022
Figure Russia Vaccine Adjuvants Sales Forecast 2017-2022
Figure Italy Vaccine Adjuvants Sales Forecast 2017-2022
Figure Turkey Vaccine Adjuvants Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Vaccine Adjuvants Sales Forecast 2017-2022
Figure Israel Vaccine Adjuvants Sales Forecast 2017-2022
Figure UAE Vaccine Adjuvants Sales Forecast 2017-2022
Figure Iran Vaccine Adjuvants Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Vaccine Adjuvants Sales Forecast 2017-2022
Figure Nigeria Vaccine Adjuvants Sales Forecast 2017-2022
Figure Egypt Vaccine Adjuvants Sales Forecast 2017-2022
Figure Algeria Vaccine Adjuvants Sales Forecast 2017-2022
Table EMEA Vaccine Adjuvants Sales Forecast by Type (2017-2022)
Table EMEA Vaccine Adjuvants Market Share Forecast by Type (2017-2022)
Table EMEA Vaccine Adjuvants Sales Forecast by Application (2017-2022)
Table EMEA Vaccine Adjuvants Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List